Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

por Blomqvist, C., Wiklund, T., Tarkkanen, M., Elomaa, I., Virolainen, M.
Publicado 1993

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

por Saarto, T., Blomqvist, C., Rissanen, P., Auvinen, A., Elomaa, I.
Publicado 1997

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

por Poikonen, P, Saarto, T, Lundin, J, Joensuu, H, Blomqvist, C
Publicado 1999

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast...

por Saarto, T., Blomqvist, C., Risteli, J., Risteli, L., Sarna, S., Elomaa, I.
Publicado 1998

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

por Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., Elomaa, I.
Publicado 1997

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

por Vahteristo, P, Eerola, H, Tamminen, A, Blomqvist, C, Nevanlinna, H
Publicado 2001

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

por Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
Publicado 2004

Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke

por Nilsson, G, Holmberg, L, Garmo, H, Terent, A, Blomqvist, C
Publicado 2009

Type III collagen metabolism in soft tissue sarcomas.

por Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., Risteli, J.
Publicado 1992

Type I and type III collagen metabolites in adult osteosarcoma patients.

por Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I.
Publicado 1996

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.

por Blomqvist, C., Risteli, L., Risteli, J., Virkkunen, P., Sarna, S., Elomaa, I.
Publicado 1996

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

por Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M.
Publicado 1997

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer

por Saarto, T, Vehmanen, L, Elomaa, I, Välimäki, M, Mäkelä, P, Blomqvist, C
Publicado 2001

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

por Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S.
Publicado 1995

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to te...

por Jahkola, T, Toivonen, T, Smitten, K von, Virtanen, I, Wasenius, V-M, Blomqvist, C
Publicado 1999

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised...

por Blomqvist, C., Tiusanen, K., Elomaa, I., Rissanen, P., Hietanen, T., Heinonen, E., Gröhn, P.
Publicado 1992

Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.

por Blomqvist, C., Huuhtanen, R., Pan, Y., Wiklund, T., Tarkkanen, M., Virolainen, M., Tribukait, B.
Publicado 1996

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer

por Poikonen, P, Sjöström, J, Amini, R-M, Villman, K, Ahlgren, J, Blomqvist, C
Publicado 2005

The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas

por Maula, S, Huuhtanen, R L, Blomqvist, C P, Wiklund, T A, Laurila, P, Ristamäki, R
Publicado 2001

Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tum...

por Voutilainen, S., Heikkilä, P., Bartkova, J., Nevanlinna, H., Blomqvist, C., Bartek, J., Mattson, J.
Publicado 2022